[1]
A. . Chandra, “Identification of biorelevant dissolution media to assess biopharmaceutical performance of erlotinib formulation with enhanced bioavailability using physiologybased pharmacokinetic modeling”, AJP, vol. 16, no. 2, Jun. 2022.